Status:
COMPLETED
Local Infiltration Analgesia Vs. Interscalene Block in Total Shoulder Arthorplasty
Lead Sponsor:
University of Missouri-Columbia
Conditions:
Shoulder Osteoarthritis
Cuff Tear Arthropathy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Pain management following total shoulder arthroplasty is an important factor in determining patient outcomes and satisfaction. Interscalene brachial plexus blockade has been used successfully to minim...
Detailed Description
1. SELECTION OF SUBJECTS • Inclusion Criteria: Adult patients (18 years of age or greater) undergoing primary anatomic or reverse total shoulder arthroplasty secondary to osteoarthritis, cuff tear art...
Eligibility Criteria
Inclusion
- Adult patients (18 years of age or greater)
- Primary anatomic or reverse total shoulder arthroplasty secondary to osteoarthritis, cuff tear arthropathy, or massive irreparable rotator cuff tear
Exclusion
- Narcotic dependent
- Previous ipsilateral open shoulder surgery
- Chronic pain syndromes (fibromyalgia)
- Contraindication to regional anesthesia
- Cervical radiculopathy
- Workers compensation insurance
- Mentally Disabled.
- Pregnant Patients
Key Trial Info
Start Date :
August 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 13 2022
Estimated Enrollment :
78 Patients enrolled
Trial Details
Trial ID
NCT04415931
Start Date
August 15 2020
End Date
March 13 2022
Last Update
March 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Missouri
Columbia, Missouri, United States, 65212